Direct Pulp Capping: Which is the Most Effective Biomaterial? A Retrospective Clinical Study
Autor(a) principal: | |
---|---|
Data de Publicação: | 2019 |
Outros Autores: | , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10316/107145 https://doi.org/10.3390/ma12203382 |
Resumo: | (1) Background: Recently, tricalcium silicate cements, such as Biodentine™, have emerged. This biomaterial has a calcium hydroxide base and characteristics like mineral aggregate trioxide cements, but has tightening times that are substantially more suitable for their application and other clinical advantages. (2) Methods: A retrospective clinical study was conducted with 20 patients, which included a clinical evaluation of the presence or absence of pulp inflammation compatible symptoms, radiographic evaluation of the periapical tissues, and structural alterations of the coronary restoration that supports pulp capping therapies with Biodentine™ and WhiteProRoot®MTA. (3) Results: This clinical study revealed similar success rates between mineral trioxide cement and tricalcium silicates cements at 6 months, with 100% and 95% success rates, respectively. There were no statistically significant differences between both biomaterials and between these and the various clinical circumstances, namely the absolute isolation of the operating field, exposure size, the aetiology of exposure, and even the type of restorative material used. (4) Conclusions: Biodentine™ demonstrated a therapeutic effect on the formation of a dentin bridge accompanied by slight inflammatory signs, with a high clinical success rate, indicating the possibility of its effective and safe use in dental pulp direct capping in humans, similar to the gold standard material. |
id |
RCAP_d0dd77ca95ac05a1b34ca83067a9ba70 |
---|---|
oai_identifier_str |
oai:estudogeral.uc.pt:10316/107145 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Direct Pulp Capping: Which is the Most Effective Biomaterial? A Retrospective Clinical Studybiocompatibilitybiomaterialsclinicaldirect pulp cappingpulp vitality(1) Background: Recently, tricalcium silicate cements, such as Biodentine™, have emerged. This biomaterial has a calcium hydroxide base and characteristics like mineral aggregate trioxide cements, but has tightening times that are substantially more suitable for their application and other clinical advantages. (2) Methods: A retrospective clinical study was conducted with 20 patients, which included a clinical evaluation of the presence or absence of pulp inflammation compatible symptoms, radiographic evaluation of the periapical tissues, and structural alterations of the coronary restoration that supports pulp capping therapies with Biodentine™ and WhiteProRoot®MTA. (3) Results: This clinical study revealed similar success rates between mineral trioxide cement and tricalcium silicates cements at 6 months, with 100% and 95% success rates, respectively. There were no statistically significant differences between both biomaterials and between these and the various clinical circumstances, namely the absolute isolation of the operating field, exposure size, the aetiology of exposure, and even the type of restorative material used. (4) Conclusions: Biodentine™ demonstrated a therapeutic effect on the formation of a dentin bridge accompanied by slight inflammatory signs, with a high clinical success rate, indicating the possibility of its effective and safe use in dental pulp direct capping in humans, similar to the gold standard material.MDPI2019-10-16info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://hdl.handle.net/10316/107145http://hdl.handle.net/10316/107145https://doi.org/10.3390/ma12203382eng1996-194431623190Paula, AnabelaCarrilho, EuniceLaranjo, MafaldaAbrantes, Ana M.Casalta-Lopes, JoãoBotelho, Maria FilomenaMarto, Carlos MiguelFerreira, Manuel M.info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-06-12T08:26:54Zoai:estudogeral.uc.pt:10316/107145Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T21:23:30.516799Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Direct Pulp Capping: Which is the Most Effective Biomaterial? A Retrospective Clinical Study |
title |
Direct Pulp Capping: Which is the Most Effective Biomaterial? A Retrospective Clinical Study |
spellingShingle |
Direct Pulp Capping: Which is the Most Effective Biomaterial? A Retrospective Clinical Study Paula, Anabela biocompatibility biomaterials clinical direct pulp capping pulp vitality |
title_short |
Direct Pulp Capping: Which is the Most Effective Biomaterial? A Retrospective Clinical Study |
title_full |
Direct Pulp Capping: Which is the Most Effective Biomaterial? A Retrospective Clinical Study |
title_fullStr |
Direct Pulp Capping: Which is the Most Effective Biomaterial? A Retrospective Clinical Study |
title_full_unstemmed |
Direct Pulp Capping: Which is the Most Effective Biomaterial? A Retrospective Clinical Study |
title_sort |
Direct Pulp Capping: Which is the Most Effective Biomaterial? A Retrospective Clinical Study |
author |
Paula, Anabela |
author_facet |
Paula, Anabela Carrilho, Eunice Laranjo, Mafalda Abrantes, Ana M. Casalta-Lopes, João Botelho, Maria Filomena Marto, Carlos Miguel Ferreira, Manuel M. |
author_role |
author |
author2 |
Carrilho, Eunice Laranjo, Mafalda Abrantes, Ana M. Casalta-Lopes, João Botelho, Maria Filomena Marto, Carlos Miguel Ferreira, Manuel M. |
author2_role |
author author author author author author author |
dc.contributor.author.fl_str_mv |
Paula, Anabela Carrilho, Eunice Laranjo, Mafalda Abrantes, Ana M. Casalta-Lopes, João Botelho, Maria Filomena Marto, Carlos Miguel Ferreira, Manuel M. |
dc.subject.por.fl_str_mv |
biocompatibility biomaterials clinical direct pulp capping pulp vitality |
topic |
biocompatibility biomaterials clinical direct pulp capping pulp vitality |
description |
(1) Background: Recently, tricalcium silicate cements, such as Biodentine™, have emerged. This biomaterial has a calcium hydroxide base and characteristics like mineral aggregate trioxide cements, but has tightening times that are substantially more suitable for their application and other clinical advantages. (2) Methods: A retrospective clinical study was conducted with 20 patients, which included a clinical evaluation of the presence or absence of pulp inflammation compatible symptoms, radiographic evaluation of the periapical tissues, and structural alterations of the coronary restoration that supports pulp capping therapies with Biodentine™ and WhiteProRoot®MTA. (3) Results: This clinical study revealed similar success rates between mineral trioxide cement and tricalcium silicates cements at 6 months, with 100% and 95% success rates, respectively. There were no statistically significant differences between both biomaterials and between these and the various clinical circumstances, namely the absolute isolation of the operating field, exposure size, the aetiology of exposure, and even the type of restorative material used. (4) Conclusions: Biodentine™ demonstrated a therapeutic effect on the formation of a dentin bridge accompanied by slight inflammatory signs, with a high clinical success rate, indicating the possibility of its effective and safe use in dental pulp direct capping in humans, similar to the gold standard material. |
publishDate |
2019 |
dc.date.none.fl_str_mv |
2019-10-16 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10316/107145 http://hdl.handle.net/10316/107145 https://doi.org/10.3390/ma12203382 |
url |
http://hdl.handle.net/10316/107145 https://doi.org/10.3390/ma12203382 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
1996-1944 31623190 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.publisher.none.fl_str_mv |
MDPI |
publisher.none.fl_str_mv |
MDPI |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799134122163044352 |